Global metabolic responses of NMRI mice to an experimental plasmodium berghei infection

Journal of Proteome Research

Volumn 7, Issue 9, 2008, Pages 3948-3956

  Li, Jia V ^a,b   Wang, Yulan ^a,c   Saric, Jasmina ^a,b   Nicholson, Jeremy K ^a   Dirnhofer, Stephan ^d   Singer, Burton H ^b   Tanner, Marcel ^b   Wittlin, Sergio ^e   Holmes, Elaine ^a   Utzinger, Jürg ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d PRINCETON UNIVERSITY   (United States)

^e Wuhan National Laboratory for Optoelectronics   (China)

Author keywords

1h nmr spectroscopy; Malaria; Metabolomics; Metabonomics; Mouse; Multivariate data analysis; Plasma; Plasmodium berghei; Urine

Indexed keywords

DIMETHYLAMINE; PIPECOLIC ACID; TAURINE; TRIMETHYLAMINE OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITOSIS; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; URINALYSIS; ANIMAL; BLOOD; DISEASE MODEL; MALARIA; METABOLISM; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARASITOLOGY; PATHOGENICITY; URINE;

MUS; PLASMODIUM BERGHEI;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; MAGNETIC RESONANCE SPECTROSCOPY; MALARIA; MICE; MULTIVARIATE ANALYSIS; PLASMODIUM BERGHEI;

EID: 55249099594     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800209d     Document Type: Article

References (51)

1. Snow, R. W.; Guerra, C. A.; Noor, A. M.; Myint, H. Y.; Hay, S. I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434, 214-217.
2. Lopez, A. D.; Mathers, C. D.; Ezzati, M.; Jamison, D. T.; Murray, C. J. L. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancer 2006, 367, 1747-1757.
3. Breman, J. G. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 2001, 64 (1-2 Suppl), 1-11.
4. Tuteja, R. Malaria-an overview. FEBS J. 2007, 274, 4670-4679.
5. Rosenthal, P. J.; Lee, G. K.; Smith, R. E. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. J. Clin. Invest. 1993, 91, 1052-1056.
6. Stevenson, M. M.; Tam, M. F. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin. Exp. Immunol. 1993, 92, 77-83.
7. Chen, M.; Theander, T. G.; Christensen, S. B.; Hviid, L.; Zhai, L.; Kharazmi, A. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob. Agents Chemother. 1994, 38, 1470-1475.
8. Campanella, G. S. V.; Tager, A. M.; El Khoury, J. K.; Thomas, S. Y.; Abrazinski, T. A.; Manice, L. A.; Colvin, R. A.; Luster, A. D. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 4814-4819.
9. Tanner, M.; de Savigny, D. Malaria eradication back on the table. Bull. World Health Organ. 2008, 82, 84.
10. Coura, J. R.; Suarez-Mutis, M.; Ladeia-Andrade, S. A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection-a review. Mem. Inst. Oswaldo Cruz 2006, 101, 229-237.
11. Njama-Meya, D.; Kamya, M. R.; Dorsey, G. Asymptomatic para-sitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children. Trop. Med. Int. Health 2004, 9, 862-868.
12. Wongsrichanalai, C.; Barcus, M. J.; Muth, S.; Sutamihardja, A.; Wernsdorfer, W. H. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am. J. Trop. Med. Hyg. 2007, 77, 119-127.
13. Daily, J. P.; Scanfeld, D.; Pochet, N.; Le Roch, K.; Plouffe, D.; Kamal, M.; Sarr, O.; Mboup, S.; Ndir, O.; Wypij, D.; Levasseur, K.; Thomas, E.; Tamayo, P.; Dong, C.; Zhou, Y.; Lander, E. S.; Ndiaye, D.; Wirth, D.; Winzeler, E. A.; Mesirov, J. P.; Regev, A. Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature 2007, 450, 1091-1095.
14. Nicholson, J. K.; Wilson, I. D. High-resolution proton magnetic- resonance spectroscopy of biological fluids. Prog. NMR Spectrosc. 1989, 21, 449-501.
15. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29, 1181-1189.
16. Nicholson, J. K.; Connelly, J.; Lindon, J. C.; Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discovery 2002, 1, 153-161.
17. Martin, F. P. J.; Dumas, M. E.; Wang, Y. L.; Legido-Quigley, C.; Yap, I. K. S.; Tang, H.; Zirah, S.; Murphy, G. M.; Cloarec, O.; Lindon, J. C.; Sprenger, N.; Fay, L. B.; Kochhar, S.; van Bladeren, P.; Holmes, E.; Nicholson, J. K. A top-down systems biology view of micro-biome-mammalian metabolic interactions in a mouse model. Mol. Syst. Biol. 2007, 3, 112.
18. Martin, F. P. J.; Wang, Y. L.; Sprenger, N.; Yap, I. K. S.; Lundstedt, T.; Lek, P.; Rezzi, S.; Ramadan, Z.; van Bladeren, P.; Fay, L. B.; Kochhar, S.; Lindon, J. C.; Holmes, E.; Nicholson, J. K. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol. Syst. Biol. 2008, 4, 157.
19. Wang, Y. L.; Holmes, E.; Nicholson, J. K.; Cloarec, O.; Chollet, J.; Tanner, M.; Singer, B. H.; Utzinger, J. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 12676-12681.
20. Wang, Y. L.; Utzinger, J.; Xiao, S. H.; Xue, J.; Nicholson, J. K.; Tanner, M.; Singer, B. H.; Holmes, E. System level metabolic effects of a Schistosoma japonicum infection in the Syrian hamster. Mol. Biochem. Parasitol. 2006, 146, 1-9.
21. Wang, Y. L.; Utzinger, J.; Saric, J.; Li, V. L.; Burckhardt, J.; Dirnhofer, S.; Nicholson, J. K.; Singer, B. H.; Brun, R.; Holmes, E. Global metabolic responses of mice to Trypanosoma brucei brucei infection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 6127-6132.
22. Franke-Fayard, B.; Trueman, H.; Ramesar, J.; Mendoza, J.; van der Keur, M.; van der Linden, R.; Sinden, R. E.; Waters, A. P.; Janse, C. J. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol. Biochem. Parasitol. 2004, 137, 23-33.
23. Vennerstrom, J. L.; Arbe-Barnes, S.; Brun, R.; Charman, S. A.; Chiu, F. C.; Chollet, J.; Dong, Y.; Dorn, A.; Hunziker, D.; Matile, H.; Mcintosh, K.; Padmanilayam, M.; Santo Tomas, J.; Schemer, C.; Scorneaux, B.; Tang, Y.; Urwyler, H.; Wittlin, S.; Charman, W. N. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 2004, 430, 900-904.
24. Trygg, J.; Wold, S. Orthogonal projections to latent structures (O- PLS). J. Chemom. 2002, 16, 119-128.
25. Wilson, I. D.; Nicholson, J. K. Topics in xenobiochemistry: do metabolic pathways exist for xenobiotics? The micro-metabolism hypothesis. Xenobiotica 2003, 33, 887-901.
26. Nicholson, J. K.; Holmes, E.; Wilson, I. D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 2005, 3, 431-438.
27. 13C NMR spectroscopy of human blood plasma. Anal. Chem. 1995, 67, 793-811.
28. Wang, Y. L.; Lawler, D.; Larson, B.; Ramadan, Z.; Kochhar, S.; Holmes, E.; Nicholson, J. K. Metabonomic investigations of aging and caloric restriction in a life-long dog study. J. Proteome Res. 2007, 6, 1846-1854.
29. Teague, C. R.; Dhabhar, F. S.; Barton, R. H.; Beckwith-Hall, B.; Powell, J.; Cobain, M.; Singer, B.; McEwen, B. S.; Lindon, J. C.; Nicholson, J. K.; Holmes, E. Metabonomic studies on the physiological effects of acute and chronic psychological stress in Sprague-Dawley rats. J. Proteome Res. 2007, 6, 2080-2093.
30. Kruckeberg, W. C.; Sander, B. J.; Sullivan, D. C. Plasmodium berghei: glycolytic enzymes of the infected mouse erythrocyte. Exp. Parasitol. 1981, 51, 438-443.
31. Roth, E. F. J.; Calvin, M. C.; Max-Audit, I.; Rosa, J.; Rosa, R. The enzymes of the glycolytic pathway in erythrocytes infected with Plasmodium falciparum malaria parasites. Blood 1988, 72, 1922-1925.
32. Lang-Unnasch, N.; Murphy, A. D. Metabolic changes of the malaria parasite during the transition from the human to the mosquito host. Annu. Rev. Microbiol. 1998, 52, 561-590.
33. Mehta, M.; Sonawat, H. M.; Sharma, S. Malaria parasite-infected erythrocytes inhibit glucose utilization in uninfected red cells. FEBS Lett. 2005, 579, 6151-6158.
34. Agbenyega, T.; Angus, B. J.; Bedu-Addo, G.; Baffoe-Bonnie, B.; Guyton, T.; Stacpoole, P. W.; Krishna, S. Glucose and lactate kinetics in children with severe malaria. J. Clin. Endocrinol. Metab. 2000, 85, 1569-1576.
35. Ehrhardt, S.; Mockenhaupt, F. P.; Anemana, S. D.; Otchwemah, R. N.; Wichmann, D.; Cramer, J. P.; Bienzle, U.; Burchard, G. D.; Brattig, N. W. High levels of circulating cardiac proteins indicate cardiac impairment in African children with severe Plasmodium falciparum malaria. Microbes Infect. 2005, 7, 1204-1210.
36. Shukla-Dave, A.; Degaonkar, M.; Roy, R.; Murthy, P. K.; Murthy, P. S.; Raghunathan, P.; Chatterjee, R. K. Metabolite mapping of human filarial parasite Brugia malayi with nuclear magnetic resonance. Magn. Reson. Imaging 1999, 17, 1503-1509.
37. Sharma, U.; Atri, S.; Sharma, M. C.; Sarkar, C.; Jagannathan, N. R. Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study. Magn. Reson. Imaging 2003, 21, 145-153.
38. Ancelin, M. L.; Vial, H. J. Choline kinase activity in Plasmodium- infected erythrocytes: characterization and utilization as a parasite- specific marker in malarial fractionation studies. Biochim. Biophys. Acta 1986, 875, 52-58.
39. Lehane, A. M.; Saliba, K. J.; Allen, R. J. W.; Kirk, K. Choline uptake into the malaria parasite is energized by the membrane potential. Biochem. Biophys. Res. Commun. 2004, 320, 311-317.
40. Saïssy, J. M.; Vitris, M.; Diatta, B.; Kempf, J.; Adam, F.; Sarthou, J. L. Severe malaria in African adults living in a seasonal endemic area. Intensive Care Med. 1994, 20, 437-441.
41. Fujita, T.; Hada, T.; Higashino, K. Origin of D- and L-pipecolic acid in human physiological fluids: a study of the catabolic mechanism to pipecolic acid using the lysine loading test. Clin. Chim. Acta 1999, 287, 145-156.
42. Danks, D. M.; Tippett, P.; Adams, C.; Campbell, P. Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism. J. Pediatr. 1975, 86, 382-387.
43. Kawasaki, H.; Hori, T.; Nakajima, M.; Takeshita, K. Plasma levels of pipecolic acid in patients with chronic liver disease. Hepatology 1988, 8, 286-289.
44. Roesel, R. A.; Carroll, J. E.; Rizzo, W. B.; van der Zalm, T.; Hahn, D. A. Dyggve-Melchior-Clausen syndrome with increased pipecolic acid in plasma and urine. J. Inherit. Metab. Dis. 1991, 14, 876-880.
45. Matsuda, Y.; Fujita, T.; Hada, T.; Higashino, K. Comparative study on the correlation of plasma gamma-arninobutyric acid and pipecolic acid with liver function in patients with liver cirrhosis. Hepatol Res. 2000, 18, 132-140.
46. Plecko, B.; Stockler-Ipsiroglu, S.; Paschke, E.; Erwa, W.; Struys, E. A.; Jakobs, C. Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann. Neurol. 2000, 48, 121-125.
47. Nomura, Y.; Okuma, Y.; Segawa, T.; Schmidt-Glenewinkel, T.; Giacobini, E. Comparison of synaptosomal and glial uptake of pipecolic acid and GABA in rat brain. Neurochem. Res. 1981, 6, 391-400.
48. Day, N. P. J.; Hien, T. T.; Schollaardt, T.; Loc, P. P.; Chuong, L. V.; Chau, T. T. H.; Mai, N. T. H.; Phu, N. H.; Sinn, D. X.; White, N. J.; Ho, M. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J. Infect. Dis. 1999, 180, 1288-1297.
49. Gartland, K. P. R.; Bonner, F. W.; Nicholson, J. K. Investigations into the biochemical effects of region-specific nephrotoxins. Mol Pharmacol 1989, 35, 242-250.
50. 1H nuclear magnetic resonance spectroscopic investigation of urine for diagnostic and clinical assessment of methanol intoxication. Basic Clin. Pharmacol. Toxicol. 2005, 97, 257-260.
51. Dumas, M. E.; Barton, R. H.; Toye, A.; Cloarec, O.; Blancher, C.; Rothwell, A.; Fearnside, J.; Tatoud, R.; Blanc, V.; Lindon, J. C.; Mitchell, S. C.; Holmes, E.; McCarthy, M. I.; Scott, J.; Gauguier, D.; Nicholson, J. K. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 12511-12516.